skin

fever

stomach acid

antibody response

It is designed as a first line of defense against pathogens.

It is designed to dispose of pathogens after they have been found.

It is designed to attack pathogens not found by the specific immune system.

It is designed to deal only with pathogens that are not a serious threat to the body.

The primary response for the antigen was greater than the secondary response because antibodies were fighting the antigen.

The primary response for the antigen was greater than the secondary because a vaccine was given to fight the antigen.

The secondary response for the antigen was greater than the primary response because memory cells were present specifically for the antigen.

The secondary response for the antigen was greater than the primary response because there were not enough memory cells.

1

2

3

4

Cases increased after the introduction of the vaccine.

Cases decreased after the introduction of the vaccine.

Hospitalizations increased after the introduction of the vaccine.

Hospitalizations decreased after the introduction of the vaccine.

Yes because it is generally safe to take antibiotics.

Yes because the virus will be controlled with the antibiotics.

No because the infection was viral and antibiotics do not function for viruses.

No because the antibiotics prescribed were not specific for the bacterial infection.

Diseases spread by animals will be less common as habitats change and are destroyed.

More people may become exposed to diseases that were previously contained in specific

areas.

Hospitals will be under less strain than normal as changes in climate begin to weaken the

impacts of disease.

Changes in the environment will have no impact on human health but will have increased

impact on ecosystems.

The Lynch mutation has the largest risk difference on an individual’s likelihood to be

diagnosed with ovarian cancer when compared to the general population.

The Lynch mutation has the largest risk difference on an individual's likelihood to be

diagnosed with colorectal cancer when compared to the general population.

The Lynch mutation has the smallest risk difference on an individual's likelihood to be

diagnosed with cancer a second time within 15 years of the initial diagnosis.

The Lynch mutation has the smallest risk difference on an individual’s likelihood to be

diagnosed with endometrial cancer when compared to the general population.